Water-aided colonoscopy is rapidly becoming more widely adopted by lower gastrointestinal endoscopists, and has previously been shown to increase patient comfort, adenoma detection rate and bowel cleanliness, albeit potentially at the cost of increased insertion time [1]. Two main variations in technique exist. Water exchange (WE) involves only using water to distend the bowel and […]
Category: Uncategorized
#FGBlog: #FGBlog: How can we support patients with advanced chronic liver disease better in our units?
Deaths from advanced chronic liver disease are increasing over the past 50 years1. Regardless of what type of gastroenterologist you are, you can probably think of a case of a patient with advanced chronic liver disease who has died. You may even have reflected on whether the circumstances could have been different if only we […]
#FGBlog: 2023 in review: summary of the 2023 #FGCup
We have just come to the end of our annual (friendly) competition, the #FGCup. We are very lucky to have had eight fantastic papers be included in a tournament and we thank our editor-in chief, Professor Mark Beattie, in helping to choose these. We also thank all our authors and reviewers for which this would […]
#FGBlog: Measuring disability in IBD, and its predictive value in treatment decisions
The importance of Patient Reported Outcome Measures (PROMs) in inflammatory bowel disease (IBD) is now widely appreciated. Despite this, only relatively recently were PROMs routinely incorporated into clinical trials as outcomes. Current tools available include the IBD questionnaire (IBDQ) for measuring health-related quality of life (HRQoL) and IBD-control for measuring patients’ perspective of disease control. […]
#FGBlog: Dedicated Barrett’s oesophagus surveillance lists: the future for better dysplasia detection?
Getting surveillance for Barrett’s oesophagus (BO) right is critical for early detection and prevention of oesophageal adenocarcinoma. When identified early, Barrett’s can be treated effectively with minimally invasive endoscopic techniques. Despite clear national guidelines on when and how to perform surveillance for BO, adherence to these guidelines is variable. In the most recent edition of […]
#FGBlog: Satellite liver centres for chronic disease vs. hepatocellular carcinoma (HCC): where do we go from here?
The “hub and spoke” model of liver transplant care that is used in some UK regions has been a concept over the past 10 years as described by John O’Grady in 20131.This sounds like a great idea on paper: you can see a patient as the hepatologist with chronic liver disease in clinic in a […]
A Year in Review: the 2022 FG Cup
As 2022 draws to a close we offer our thanks to our authors, reviewers and readers on another productive year! FG is delighted to publish pragmatic and useful advice from experts in the field, enabling practicing gastroenterologists to keep abreast of changing practice. Here we highlight the best of 2022’s papers selected by Editor-in-chief Professor […]
A new approach to coeliac disease diagnosis?
It is well-established that UK endoscopy services are under pressure, with post-Covid waiting lists pushing demand to an all-time high.1 Whilst a no-biopsy approach has been advocated in the diagnosis of coeliac disease (CD) in children since 2012, British Society of Gastroenterology (BSG) guidelines issued in 2014 still advise four duodenal biopsies for the diagnosis […]
#FGBlog – Shape of Training: ready or not
This time of year has always been an uneasy one. At school and university, it signified the end of frivolities and return to the classroom. In our professional career, it has usually signified the time for a change in workplace. Change is something that I, like many others, always struggle to adapt to. I enjoy […]
A potential new role for faecal calprotectin in monitoring biliary tract disease
Most gastroenterologists have long been familiar with faecal calprotectin (fCal), and it is widely used as a non-invasive test both to screen for the presence of inflammation in those with lower GI symptoms, and to quantitatively monitor disease activity in inflammatory bowel disease (IBD) patients. Calprotectin is a member of the S100 protein family found […]